Treatment with specific and pan-plasma membrane calcium ATPase (PMCA) inhibitors reduces malaria parasite growth in vitro and in vivo. (2022)
Attributed to:
The role of plasma membrane calcium ATPase 4 (PMCA4) in modulating Plasmodium infection and malaria severity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12936-022-04228-0
PubMed Identifier: 35768835
Publication URI: http://europepmc.org/abstract/MED/35768835
Type: Journal Article/Review
Volume: 21
Parent Publication: Malaria journal
Issue: 1
ISSN: 1475-2875